object
regulatori
cytokin
associ
viral
infect
object
studi
evalu
relat
serum
regulatori
cytokin
concentr
respiratori
syncyti
viru
rsv
diseas
method
enrol
children
age
month
diagnos
acut
respiratori
tract
infect
twenti
agematch
healthi
children
enrol
control
nasopharyng
swab
analyz
identifi
viru
revers
transcript
polymeras
chain
reaction
blood
sampl
taken
quantifi
regulatori
cytokin
concentr
includ
interleukin
il
transform
growth
factor
tgf
use
bioplex
immunoassay
enzymelink
immunosorb
assay
result
rsv
diseas
associ
great
regulatori
cytokin
respons
healthi
children
among
rsvinfect
patient
serum
p
p
significantli
elev
comparison
healthi
control
young
children
age
month
rsv
infect
significantli
lower
express
need
oxygen
therapi
sever
diseas
compar
older
children
age
month
compar
mild
group
express
level
significantli
lower
children
moder
sever
diseas
p
p
respect
level
invers
associ
total
durat
rsv
infect
symptom
r
p
conclus
children
rsv
infect
increas
serum
regulatori
cytokin
concentr
elev
express
contribut
protect
hypoxia
reduc
sever
diseas
respiratori
syncyti
viru
rsv
envelop
singlestrand
negativesens
rna
viru
belong
paramyxovirida
famili
infect
rsv
lead
caus
seriou
viral
respiratori
tract
infect
children
age
year
rsv
infect
result
spectrum
clinic
present
rang
common
cold
symptom
sever
lower
respiratori
tract
involv
requir
admiss
pediatr
intens
care
unit
grow
bodi
evid
suggest
young
children
like
develop
lifethreaten
rsv
infect
associ
complic
studi
demonstr
rsv
infect
typic
correl
potent
immun
respons
lower
respiratori
tract
due
helper
th
cell
imbal
associ
proantiinflammatori
cytokin
respons
cytokin
respons
predomin
infant
rsv
infect
contribut
pathogenesi
sever
rsv
diseas
increas
interleukin
il
studi
indic
cytokin
respons
interferon
ifn
tumor
necrosi
factor
tnf
decreas
sever
rsv
diseas
infant
data
suggest
balanc
respons
critic
mitig
rsvmediat
diseas
sever
pediatr
patient
presenc
precis
combin
cytokin
effect
regul
develop
polar
th
cell
respons
mount
respons
viral
infect
shown
defin
regulatori
cytokin
due
immunosuppress
role
viral
infect
autoimmun
diseas
exampl
inhibit
acut
inflamm
mitig
progress
imbalanc
respons
trigger
rsv
infect
recent
identifi
suppress
cytokin
contribut
induct
type
regulatori
cell
modul
product
anoth
immunosuppress
cytokin
interfer
product
respons
rsv
infect
data
indic
protect
immun
respons
regul
regulatori
cytokin
depend
infecti
agent
convers
research
demonstr
also
induc
strong
immun
respons
enhanc
rsv
diseas
evalu
role
regulatori
cytokin
rsv
diseas
character
chang
express
level
sever
regulatori
cytokin
includ
context
rsv
infect
pediatr
patient
character
role
respons
rsv
infect
studi
perform
januari
decemb
first
peopl
hospit
chenzhou
china
child
age
month
need
hospit
sign
acut
upper
respiratori
tract
infect
urti
defin
nasal
congest
rhinorrhea
lower
respiratori
tract
infect
lrti
defin
bronchiol
andor
pneumonia
fever
cough
sputum
product
wheez
tachypnea
radiolog
find
enrol
healthi
control
consist
children
met
follow
criteria
age
year
old
underw
surgeri
surgic
depart
ii
without
current
recent
clinic
symptom
respiratori
infect
ie
cough
fever
wheez
expector
anhel
etc
iii
without
histori
system
infect
children
prematur
birth
week
underli
chronic
diseas
eg
chronic
lung
diseas
congenit
heart
diseas
immunodefici
immun
diseas
asthma
combin
infect
exclud
elig
children
visit
hospit
nasopharyng
swab
blood
taken
within
h
enrol
test
presenc
rsv
level
cytokin
patient
treat
demograph
clinic
inform
also
obtain
record
clinic
inform
child
everyday
ask
parent
fill
form
physic
examin
blood
test
clinic
characterist
fever
wheez
tachypnea
respiratori
frequenc
heart
rate
presenc
retract
oxygen
satur
need
oxygen
need
intens
care
length
hospit
radiolog
find
clinic
diagnosi
individu
assess
describ
diseas
sever
use
diseas
sever
score
tabl
rsv
infect
confirm
nasopharyng
swab
use
revers
transcript
polymeras
chain
reaction
rtpcr
describ
previous
viral
load
measur
use
realtim
fluoresc
quantit
pcr
accord
standard
protocol
respiratori
viru
includ
adenoviru
influenza
parainfluenza
coronaviru
bocaviru
human
metapneumoviru
detect
blood
sputum
cultur
indic
perform
exclud
viral
bacteri
infect
studi
approv
hospit
ethic
committe
first
peopl
hospit
chenzhou
china
written
inform
consent
obtain
parent
guardian
particip
serum
sampl
measur
cytokin
concentr
serum
measur
enzymelink
immunosorb
assay
elisa
use
human
mous
elisa
readysetgo
ebiosci
san
diego
ca
usa
human
interleukin
elisa
kit
cusabio
wuhan
china
measur
use
bioplex
pro
assay
quick
guid
biorad
hercul
ca
usa
lower
limit
detect
cytokin
pgml
rsvinfect
patient
divid
three
group
follow
age
month
month
age
month
mean
assess
role
age
diseas
sever
progress
cytokin
profil
descript
analysi
patient
demograph
clinic
characterist
summar
frequenc
percentag
continu
variabl
summar
median
interquartil
rang
iqr
data
differ
group
rsvinfect
patient
control
differ
age
group
compar
use
fisher
exact
test
categor
variabl
mannwhitney
u
test
continu
variabl
spearman
rank
correl
coeffici
use
correl
analys
data
obey
normal
distribut
p
consid
statist
signific
outcom
relationship
differ
group
statist
analys
perform
use
spss
version
graph
gener
use
graphpad
version
januari
decemb
patient
acut
respiratori
tract
infect
healthi
control
enrol
total
met
inclus
criteria
male
averag
age
iqr
month
healthi
control
male
averag
age
iqr
month
tabl
rsvinfect
children
healthi
control
divid
group
respect
follow
age
month
vs
p
age
month
vs
p
age
month
vs
p
unbalanc
age
group
age
month
signific
differ
age
sex
feed
pattern
two
group
children
rsv
infect
significantli
higher
percentag
lymphocyt
monocyt
lower
percentag
neutrophil
eosinophil
tabl
demograph
data
laboratori
clinic
characterist
radiolog
find
clinic
diagnosi
summar
tabl
diseas
sever
paramet
also
compar
three
group
total
case
age
month
old
age
age
month
compar
children
age
month
old
children
age
month
age
month
old
significantli
like
fever
p
higher
bodi
temperatur
p
tabl
children
age
month
age
month
prolong
durat
symptom
p
p
respect
length
hospit
p
p
respect
children
age
month
addit
children
age
month
like
need
supplement
oxygen
children
age
month
p
although
satur
signific
differ
three
age
group
diseas
sever
also
evalu
diseas
sever
score
tabl
compar
older
children
children
age
month
classifi
sever
diseas
signific
differ
three
group
symptom
cough
wheez
sputum
product
respiratori
frequenc
heart
rate
tachypnea
need
intens
care
requir
mechan
ventil
clinic
diagnosi
rsv
load
white
blood
cell
count
percentag
neutrophil
lymphocyt
eosinophil
monocyt
differ
significantli
among
three
group
understand
regulatori
cytokin
respons
rsv
diseas
examin
express
profil
variou
regulatori
cytokin
includ
rsvinfect
patient
healthi
control
fig
level
p
p
fig
b
significantli
increas
rsvinfect
patient
compar
level
healthi
control
signific
differ
found
level
two
group
fig
explain
young
children
rsv
infect
sever
diseas
import
assess
cytokin
profil
relat
age
compar
level
patient
differ
age
group
tabl
data
show
express
level
significantli
lower
children
age
month
age
month
p
p
respect
chang
level
serum
observ
group
exclud
influenc
increas
age
level
cytokin
analyz
correl
age
cytokin
level
rsvinfect
patient
healthi
control
data
shown
result
show
correl
age
level
two
group
impact
cytokin
level
sever
diseas
investig
fig
compar
mild
group
express
level
significantli
lower
children
moder
sever
diseas
p
p
respect
also
investig
correl
level
cytokin
total
durat
symptom
found
concentr
invers
correl
total
durat
symptom
r
p
tabl
similar
differ
associ
level
observ
evalu
relat
viral
infect
cytokin
respons
also
analyz
correl
among
rsv
load
cytokin
concentr
wbc
found
correl
among
paramet
studi
indic
elicit
rsv
infect
stimul
regul
cell
immun
respons
young
children
gener
peripheri
regul
cell
mediat
immunosuppress
produc
regulatori
cell
mainli
gener
peripheri
convent
induc
treg
cell
previou
studi
demonstr
immunosuppress
cytokin
inhibit
acut
inflamm
regul
balanc
respons
induc
express
could
benefit
host
respons
limit
exagger
inflammatori
respons
rsv
infect
cytokin
respons
although
possess
antiinflammatori
properti
potenti
inhibit
respons
elicit
respons
bacteri
viral
infect
find
express
profil
differ
rsvinfect
patient
healthi
control
multifunct
cytokin
studi
demonstr
produc
effector
cell
monocyt
play
pivot
role
control
diseas
sever
suppress
product
cytokin
proinflammatori
cytokin
addit
also
suppress
cell
gener
suppress
airway
hyperrespons
tissu
remodel
rsvinfect
patient
also
excess
produc
type
cell
enhanc
rsv
diseas
studi
found
express
level
significantli
lower
children
moder
sever
diseas
invers
associ
total
durat
symptom
data
indic
play
protect
role
lower
level
associ
moresever
rsv
diseas
produc
cell
play
critic
role
regul
immun
respons
rsv
infect
restrict
tcellmedi
pulmonari
inflamm
injuri
shown
potenti
suppress
activ
expans
treg
cell
product
inhibit
effector
cell
induc
cell
although
result
demonstr
increas
express
rsvinfect
pediatr
patient
express
level
correl
sever
diseas
howev
exclud
possibl
enhanc
level
affect
express
indirectli
contribut
amelior
diseas
rsvinfect
patient
novel
mechan
indic
b
lymphocyt
exert
suppress
function
viral
infect
manner
product
induc
regulatori
cell
exhibit
potenti
suppress
function
play
critic
role
maintain
immun
balanc
futur
studi
requir
evalu
correl
rsv
diseas
demonstr
older
age
invers
associ
suscept
rsv
infect
addit
decreas
risk
mannwhitney
u
test
use
determin
differ
two
group
p
consid
signific
ns
signific
hospit
diseas
sever
interestingli
children
less
significantli
lower
compar
children
age
month
old
correl
age
regulatori
cytokin
observ
known
infant
less
immatur
immun
system
includ
innat
immun
respons
adapt
respons
due
residu
matern
antibodi
may
prevent
induct
good
immun
respons
studi
reveal
cytokin
chemokin
includ
significantli
differ
age
group
children
rsv
infect
result
present
studi
shown
level
signific
lower
children
age
month
like
need
supplement
oxygen
data
indic
express
rsv
specif
play
protect
role
rsv
diseas
accord
investig
studi
shown
increas
respons
rsv
infect
lower
concentr
associ
sever
rsv
diseas
found
studi
rsv
diseas
other
demonstr
inhibit
viral
replic
found
relationship
rsv
load
diseas
present
long
time
use
indic
sever
diseas
result
rsv
infect
result
suggest
children
age
month
significantli
like
present
longer
total
durat
symptom
observ
agreement
previou
studi
demonstr
younger
children
greater
risk
infect
like
develop
sever
diseas
symptom
follow
infect
rsv
serum
level
invers
associ
total
durat
symptom
also
indic
high
level
associ
favor
outcom
contribut
recoveri
attenu
diseas
progress
rsvinfect
children
studi
limit
first
compar
serum
sampl
respiratori
secret
distant
sourc
studi
cytokin
children
rsv
infect
second
measur
regulatori
cytokin
singl
time
point
child
clear
whether
persist
attenu
time
third
small
number
children
wide
age
rang
may
includ
primari
reinfect
rsv
therefor
accord
present
data
ca
nt
evalu
signific
therapeut
cytokin
summari
show
rsv
infect
associ
alter
level
regulatori
cytokin
elev
serum
regulatori
cytokin
concentr
may
protect
hypoxia
contribut
reduc
sever
diseas
futur
studi
requir
character
regulatori
cytokin
profil
associ
rsv
infect
elucid
role
regulatori
cytokin
rsv
diseas
fig
impact
cytokin
level
sever
diseas
level
differ
diseas
sever
group
mild
n
moder
n
sever
n
analyz
mannwhitney
u
test
use
determin
differ
among
three
group
p
consid
signific
ns
signific
correl
inhibitori
cytokin
concentr
pgml
total
durat
symptom
day
rsvinfect
patient
correl
note
p
consid
signific
